| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,976 |
12,880 |
$2.10M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,047 |
4,003 |
$994K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,506 |
1,498 |
$534K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,606 |
1,585 |
$222K |
| 36415 |
Collection of venous blood by venipuncture |
6,466 |
6,281 |
$59K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
724 |
710 |
$29K |
| 80053 |
Comprehensive metabolic panel |
1,546 |
1,491 |
$13K |
| 85027 |
|
2,173 |
2,147 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
823 |
815 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,570 |
1,506 |
$10K |
| 87400 |
|
390 |
390 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
182 |
181 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
109 |
109 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,248 |
1,226 |
$7K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
79 |
78 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
803 |
758 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
113 |
112 |
$5K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
31 |
14 |
$4K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
27 |
27 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,408 |
1,334 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
33 |
30 |
$3K |
| 81001 |
|
1,099 |
1,078 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
15 |
15 |
$2K |
| 87430 |
|
140 |
139 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
14 |
14 |
$2K |
| 81003 |
|
933 |
927 |
$2K |
| 81025 |
|
251 |
251 |
$2K |
| 83690 |
|
212 |
212 |
$1K |
| 84703 |
|
134 |
132 |
$802.80 |
| 87070 |
|
101 |
100 |
$737.47 |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$172.51 |
| 84484 |
|
16 |
13 |
$166.35 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12 |
12 |
$78.98 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
12 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
12 |
$0.00 |